Inovio Pharmaceuticals Inc. (NASDAQ: INO)
$4.1700
+0.1100 ( +2.21% ) 155.6K
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Market Data
Open
$4.1700
Previous close
$4.0600
Volume
155.6K
Market cap
$106.39M
Day range
$4.0400 - $4.2150
52 week range
$3.8500 - $14.7480
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Nov 14, 2024 |
| 10-q | Quarterly Reports | 70 | Nov 14, 2024 |
| 8-k | 8K-related | 16 | Aug 13, 2024 |
| 8-k | 8K-related | 15 | Aug 08, 2024 |
| 10-q | Quarterly Reports | 68 | Aug 08, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 8-k | 8K-related | 13 | May 28, 2024 |
| 4 | Insider transactions | 1 | May 22, 2024 |
| 4 | Insider transactions | 1 | May 22, 2024 |
| 4 | Insider transactions | 1 | May 22, 2024 |